The control of melanocyte-stimulating hormone secretion.
D000818:Animals; D001921:Brain / Q000187:drug effects; D002395:Catecholamines / Q000037:antagonists & inhibitors / Q000502:physiology; D002746:Chlorpromazine / Q000494:pharmacology; D004295:Dihydroxyphenylalanine / Q000494:pharmacology; D006801:Humans; D007031:Hypothalamus / Q000502:physiology*; D007274:Injections, Intraperitoneal; D007279:Injections, Subcutaneous; D009074:Melanocyte-Stimulating Hormones / Q000008:administration & dosage / Q000037:antagonists & inhibitors / Q000097:blood / Q000378:metabolism*; D010300:Parkinson Disease / Q000503:physiopathology; D010640:Phenothiazines; D010902:Pituitary Gland / Q000378:metabolism; D051381:Rats; D012110:Reserpine / Q000494:pharmacology; D012629:Sebum / Q000378:metabolism
D002395:Catecholamines; D010640:Phenothiazines; D004295:Dihydroxyphenylalanine; D012110:Reserpine; D009074:Melanocyte-Stimulating Hormones; D002746:Chlorpromazine